|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| A01K 67/027 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C12N 15/85 | (2006.01) | ||
| A61K 49/00 | (2006.01) |
| (11) | Patento numeris | 2272539 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10006457.5 |
| Europos patento paraiškos padavimo data | 2005-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-01-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 969335 | 2004-10-19 | US | |
| 194115 | 2005-07-29 | US |
| (72) |
Chilcote, Tamie J., US
Goldstein, Jason, US
Anderson, John P., US
Walker, Donald, US
|
| (73) |
Elan Pharmaceuticals, LLC,
300 Technology Square, Third Floor, Cambridge, MA,
US
|
| (54) | Truncated fragments of alpha-synuclein in lewy body disease |
| Truncated fragments of alpha-synuclein in lewy body disease |